Department of Anesthesiology, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, U.S.A.
Department of Psychiatry, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.
Pain Pract. 2019 Jul;19(6):656-663. doi: 10.1111/papr.12789. Epub 2019 Jun 17.
Patients with chronic pain treated with opioids are at an increased risk for opioid misuse or opioid use disorder (OUD). Recent years have seen a stark increase in abuse, misuse, and diversion of prescription opioid medications. The aim of this study was to investigate trends in changing rates of opioid use disorder among patients with chronic pain.
The National Inpatient Sample (NIS) database identified chronic pain admissions with OUD from 2011 to 2015. Patients were identified from the NIS database using International Classification of Diseases (9th and 10th revisions) diagnosis codes for chronic pain and OUD. Annual estimates and trends were determined for OUD, patient characteristics, OUD among subgroups of chronic pain conditions, and discharge diagnosis.
We identified 10.3 million patients with chronic pain. Of these, 680,631 patients were diagnosed with OUD. The number of patients with OUD increased from 109,222 in 2011 to 172,680 in 2015 (P < 0.001). Similarly, there were upward trends of OUD among females (53.2% to 54.5%; P = 0.09), patients 65 to 84 years of age (11.8% to 17%; P < 0.001), Medicare-insured patients (39.5% to 46.0%; P < 0.01), patients with low annual household incomes (27.8% to 33.3%; P < 0.001), and patients with cannabinoid use disorder (7.2% to 8.3%; P = 0.01). The prevalence of OUD increased from 2011 to 2015 in patients with chronic regional pain syndrome (5.53% to 7.46%; P = 0.01) and spondylosis (1.32% to 1.81%; P < 0.001).
These findings suggest that the prevalence of OUD increased substantially from 2011 to 2015. Disparities of OUD with increasing opioid use among vulnerable populations including women, those with Medicare insurance, tobacco use disorder, and low annual income should be explored further.
接受阿片类药物治疗的慢性疼痛患者发生阿片类药物滥用或阿片类药物使用障碍(OUD)的风险增加。近年来,阿片类处方药物的滥用、误用和转移现象明显增多。本研究旨在探讨慢性疼痛患者中 OUD 发生率变化的趋势。
国家住院患者样本(NIS)数据库从 2011 年至 2015 年确定了患有 OUD 的慢性疼痛住院患者。使用国际疾病分类(第 9 版和第 10 版)慢性疼痛和 OUD 的诊断代码从 NIS 数据库中识别患者。确定了 OUD、患者特征、慢性疼痛疾病亚组中的 OUD 以及出院诊断的年度估计值和趋势。
我们确定了 1030 万例慢性疼痛患者。其中,680631 例患者被诊断为 OUD。2011 年 OUD 患者人数为 109222 例,2015 年增加到 172680 例(P<0.001)。同样,女性(53.2%至 54.5%;P=0.09)、65 至 84 岁的患者(11.8%至 17%;P<0.001)、医疗保险患者(39.5%至 46.0%;P<0.01)、低年度家庭收入患者(27.8%至 33.3%;P<0.001)和大麻素使用障碍患者(7.2%至 8.3%;P=0.01)的 OUD 发生率呈上升趋势。慢性区域性疼痛综合征(从 2011 年的 5.53%升至 2015 年的 7.46%;P=0.01)和脊椎病(从 2011 年的 1.32%升至 2015 年的 1.81%;P<0.001)患者的 OUD 患病率也从 2011 年到 2015 年增加。
这些发现表明,2011 年至 2015 年 OUD 的患病率大幅上升。应进一步探讨包括女性、医疗保险、烟草使用障碍和低收入人群在内的弱势群体中阿片类药物使用不断增加与 OUD 之间的差异。